Source documents · Archived capture
Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility (Exhibit 99.3)
Archived web capture. Preserved source — captured from www.sec.gov; archived 2026-09-26.
View original (web capture · 6 KB)
Original: sec.gov
Record facts
| File name | emergentbiosolutionstore-htm_e5514f5c281f5ae9.html |
|---|---|
| SHA-256 | f25b63ba6dda1c87a67af480042da39f048652a807fab3eaa5e4e11cac53d6f4 |
| Size | 5,981 bytes |
| Captured | 2026-09-26 |
| Source site | www.sec.gov |
File and source
- File
- emergentbiosolutionstore-htm_e5514f5c281f5ae9.html
- Size
- 5,981 bytes
- SHA-256
- f25b63ba6dda1c87a67af480042da39f048652a807fab3eaa5e4e11cac53d6f4
- Original
- www.sec.gov